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Background
cGMP plays an important role in the cardiovascular sys-
tem and is involved in smooth muscle relaxation and inhi-
bition of platelet aggregation. cGMP concentrations inside
cells are determined by an interplay of cGMP synthesis
through natriuretic peptide or NO receptor guanylyl
cyclases on the one hand and cGMP-degrading phospho-
diesterases on the other hand.
Phosphodiesterase 5 has been suggested to play a role in
cGMP hydrolysis in cardiac myocytes. Strong antihyper-
trophic effects of PDE5 inhibition by sildenafil have been
observed in animal models and clinical trials have been
started to approve sildenafil for the treatment of cardiac
hypertrophy.
Nevertheless, cGMP increases induced by nitric oxide or
natriuretic peptides in cardiac myocytes remain difficult to
assess. Currently, cGMP levels are measured by radioim-
munoassays (RIA) or enzyme-linked immunosorbent
assays (ELISA) using cGMP-specific antibodies. Although
femtomolar amounts of cGMP can be detected, relatively
high agonist concentrations are required to obtain mea-
surable cGMP increases.
Results
Here, we measured cGMP elevations by fluorescence
resonance energy transfer (FRET)-based cGMP indica-
tors to compare cGMP signals in cardiac myocytes and
smooth muscle cells.
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